NFLS - Pivotal
VC
INVESTOR TYPE
Active
STATUS
25
PROFESSIONALS
52
INVESTMENTS
36
PORTFOLIO
12
EXITS
Description
Nan Fung Life Sciences, part of Nan Fung Group, is a global investment platform focusing on life sciences. Leveraging on Nan Fung Group's capital base and long-term commitment to the area, the company aims to become a partner for scientists, entrepreneurs, corporations and investors in the life science space. Through direct investments via Pivotal bioVenture Partners funds (both in US and China) and fund investments covering full spectrum of the industry (including therapeutics, medical devices and diagnostics) and across different development stages, Nan Fung Life Sciences has presence in both US and Greater China. The firm was founded in 2017 and is based in Hong Kong.
Website
Investor Status
Actively Seeking New Investments
Year Founded
2017
Primary Investor Type
Venture Capital
Other Investor Types
Accelerator/Incubator
PE/Buyout
Primary Office
- 23rd Floor, Nan Fung Tower
- 88 Connaught Road C, Central
- Hong Kong
- Hong Kong
NFLS - Pivotal Investments (52)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Aligos Therapeutics | 10-Jan-2020 | Early Stage VC | 00000 | Biotechnology | Pre-Clinical Trials | |
| 0000000 | 10-Dec-2019 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | |
| 0000000 | 09-Oct-2019 | 00000 00000 | 000.00 | Biotechnology | Clinical Trials - Phase 3 | |
| 00000000 000000000 | 04-Sep-2019 | 00000 00000 | 0000 | Biotechnology | Stealth | |
| 000000 00000000000 | 27-Aug-2019 | 00000 00000 | 00000 | Drug Discovery | Clinical Trials - Phase 1 | 0000000 0000000 00 |
| 00000 0000000000 | 18-Jul-2019 | 00000 000000 | Pharmaceuticals | Generating Revenue | ||
| 000000000 | 10-Jun-2019 | 00000 00000 | 0000 | Biotechnology | Clinical Trials - Phase 2 | |
| 000000 000000 | 12-Apr-2019 | 0000 00000 | Diagnostic Equipment | Startup | ||
| Inozyme Pharma | 10-Apr-2019 | Early Stage VC | 000.00 | Biotechnology | Startup | |
| Karuna Therapeutics | 01-Apr-2019 | Later Stage VC | 0000 | Drug Discovery | Clinical Trials - Phase 2 | 0000000 0000000 00 |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore NFLS - Pivotal’s full profile, request a free trial.
NFLS - Pivotal Exits (12)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Galera Therapeutics | 07-Nov-2019 | IPO | 0000 | Completed |
|
| 000000 00000000000 | 28-Jun-2019 | 000 | 00000 | Completed |
|
| 0000000 0000000000 | 15-Feb-2019 | 000 | 0000 | Completed |
|
| 00000000 000 | 08-Feb-2019 | 000 | 00000 | Completed |
|
| 00000 0000000000 | 31-Oct-2018 | 000 | 0000 | Completed |
|
| 0000000 0000000000 | 26-Sep-2018 | 000 | 0000 | Completed |
|
| 0000000 | 21-Jun-2018 | 000 | 00000 | Completed |
|
| 000000 00000000000 | 25-May-2018 | 000 | 0000 | Completed |
|
| WuXi AppTec | 08-May-2018 | IPO | 00000 | Completed |
|
| Unity Biotechnology | 03-May-2018 | IPO | 0000 | Completed |
|
NFLS - Pivotal Team (13)
1 Former Team Member
You’re viewing 5 of 13 team members. Get the full list »NFLS - Pivotal Co-Investors (183)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| ARCH Venture Partners | 5 | 0 | 0 |
| Frazier Healthcare Partners | 0 | 0 | |
| Novo Holdings | 0 | 0 | |
| Sofinnova Investments | 0 | 0 | |
| HBM Healthcare Investments | 0 | 0 |